» Articles » PMID: 30794775

CCR5 Is a Therapeutic Target for Recovery After Stroke and Traumatic Brain Injury

Abstract

We tested a newly described molecular memory system, CCR5 signaling, for its role in recovery after stroke and traumatic brain injury (TBI). CCR5 is uniquely expressed in cortical neurons after stroke. Post-stroke neuronal knockdown of CCR5 in pre-motor cortex leads to early recovery of motor control. Recovery is associated with preservation of dendritic spines, new patterns of cortical projections to contralateral pre-motor cortex, and upregulation of CREB and DLK signaling. Administration of a clinically utilized FDA-approved CCR5 antagonist, devised for HIV treatment, produces similar effects on motor recovery post stroke and cognitive decline post TBI. Finally, in a large clinical cohort of stroke patients, carriers for a naturally occurring loss-of-function mutation in CCR5 (CCR5-Δ32) exhibited greater recovery of neurological impairments and cognitive function. In summary, CCR5 is a translational target for neural repair in stroke and TBI and the first reported gene associated with enhanced recovery in human stroke.

Citing Articles

Parvalbumin interneurons regulate rehabilitation-induced functional recovery after stroke and identify a rehabilitation drug.

Okabe N, Wei X, Abumeri F, Batac J, Hovanesyan M, Dai W Nat Commun. 2025; 16(1):2556.

PMID: 40089466 DOI: 10.1038/s41467-025-57860-0.


Biosafety and mental health: Virus induced cognitive decline.

Du C, Li G, Han G Biosaf Health. 2025; 5(3):159-167.

PMID: 40078510 PMC: 11895046. DOI: 10.1016/j.bsheal.2023.04.002.


Translatome analysis reveals cellular network in DLK-dependent hippocampal glutamatergic neuron degeneration.

Ritchie E, Acar D, Zhong S, Pu Q, Li Y, Zheng B Elife. 2025; 13.

PMID: 40067879 PMC: 11896613. DOI: 10.7554/eLife.101173.


Sex Affects Cognitive Outcomes in HIV-1 Tat Transgenic Mice: Role of CCR5.

Simons C, Kim S, Hahn Y, Boake-Agyei A, Nass S, Vo P ASN Neuro. 2025; 17(1):2447338.

PMID: 39805095 PMC: 11877617. DOI: 10.1080/17590914.2024.2447338.


Beyond the traditional distinctions of genome editing: evaluating a vulnerability framework.

Angelioudaki I, Badea A, Bodo M, Fernandez-Soto D, Karyampa E, Kokkinakis A Front Genome Ed. 2024; 6:1426228.

PMID: 39534509 PMC: 11556113. DOI: 10.3389/fgeed.2024.1426228.


References
1.
Fisher M, Holland C, Merzenich M, Vinogradov S . Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am J Psychiatry. 2009; 166(7):805-11. PMC: 2720319. DOI: 10.1176/appi.ajp.2009.08050757. View

2.
Brown C, Li P, Boyd J, Delaney K, Murphy T . Extensive turnover of dendritic spines and vascular remodeling in cortical tissues recovering from stroke. J Neurosci. 2007; 27(15):4101-9. PMC: 6672555. DOI: 10.1523/JNEUROSCI.4295-06.2007. View

3.
Wahlund L, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M . A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001; 32(6):1318-22. DOI: 10.1161/01.str.32.6.1318. View

4.
Shin J, Cho Y, Beirowski B, Milbrandt J, Cavalli V, DiAntonio A . Dual leucine zipper kinase is required for retrograde injury signaling and axonal regeneration. Neuron. 2012; 74(6):1015-22. PMC: 3383631. DOI: 10.1016/j.neuron.2012.04.028. View

5.
Chollet F, Tardy J, Albucher J, Thalamas C, Berard E, Lamy C . Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011; 10(2):123-30. DOI: 10.1016/S1474-4422(10)70314-8. View